Should NICE evaluate complementary and alternative medicines?
- PMID: 17347234
- PMCID: PMC1819538
- DOI: 10.1136/bmj.39122.551250.BE
Should NICE evaluate complementary and alternative medicines?
Abstract
Demand for complementary and alternative medicine is high despite limited evidence. Linda Franck and colleagues believe that a thorough review by NICE would benefit the NHS and patients, but David Colquhoun argues that it cannot afford to re-examine evidence that has shown little benefit
Conflict of interest statement
Comment in
-
Appraisals of specific treatments are needed.BMJ. 2007 Mar 24;334(7594):600. doi: 10.1136/bmj.39156.570208.FA. BMJ. 2007. PMID: 17379872 Free PMC article. No abstract available.
Comment on
-
Should NICE evaluate complementary and alternative medicine?BMJ. 2007 Mar 10;334(7592):506. doi: 10.1136/bmj.39122.512211.BE. BMJ. 2007. PMID: 17347233 Free PMC article.
References
-
- Smallwood C. The role of complementary and alternative medicine in the NHS. www.freshminds.co.uk/PDF/THE%20REPORT.pdf
-
- NICE. NICE guidance by type. .www.nice.org.uk/guidance/type
-
- NICE. NICE annual report 2005-6. London: NICE, 2006.
-
- House of Lords Science and Technology Committee. Sixth report: complementary and alternative medicine. London: Stationery Office, 2000. www.parliament.the-stationery-office.co.uk/pa/ld199900/ldselect/ldsctech...
-
- Colquhoun D. Debate: UK government funds CAM research. Focus on Alternative and Complementary Therapies (FACT) 2003;8:400-1.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical